Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration

MLA

Cherif, Mahamoud Sama, et al. “Immunogenicity of Novel Nanoparticle-Coated MSP-1 C-Terminus Malaria DNA Vaccine Using Different Routes of Administration.” Vaccine, vol. 29, no. 48, Nov. 2011, pp. 9038–50. EBSCOhost, https://doi.org/10.1016/j.vaccine.2011.09.031.

APA

Cherif, M. S., Shuaibu, M. N., Kurosaki, T., Helegbe, G. K., Kikuchi, M., Yanagi, T., Tsuboi, T., Sasaki, H., & Hirayama, K. (2011). Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Vaccine, 29(48), 9038–9050. https://doi.org/10.1016/j.vaccine.2011.09.031

Chicago

Cherif, Mahamoud Sama, Mohammed Nasir Shuaibu, Tomoaki Kurosaki, Gideon Kofi Helegbe, Mihoko Kikuchi, Tetsuo Yanagi, Takafumi Tsuboi, Hitoshi Sasaki, and Kenji Hirayama. 2011. “Immunogenicity of Novel Nanoparticle-Coated MSP-1 C-Terminus Malaria DNA Vaccine Using Different Routes of Administration.” Vaccine 29 (48): 9038–50. doi:10.1016/j.vaccine.2011.09.031.